Lipocine (LPCN) Earnings Date, Estimates & Call Transcripts $4.84 -0.05 (-1.02%) (As of 01:56 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lipocine Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 6EstimatedActual EPS (Nov. 7) -$0.44 Missed By -$0.44 Lipocine issued Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.44. With a trailing EPS of -$0.76, Lipocine's earnings are expected to decrease next year, from ($0.78) to ($0.94) per share. LPCN Upcoming EarningsLipocine's next earnings date is estimated for Thursday, March 6, 2025, based off prior year's reporting schedules. Get Lipocine Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lipocine and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLPCN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LPCN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wide Moat ResearchA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”Learn how to protect yourself too, click here. Lipocine Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.78) EPSNext Year EPS Consensus Estimate: ($0.94) EPS Lipocine Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/6/2025(Estimated)------- 11/7/2024Q3 2024--$0.44 -$0.44-$0.44--8/8/2024Q2 2024--$0.56 -$0.56-$0.56-$0.09M5/9/2024Q1 2024-$0.66+$0.66$0.66-$7.62M3/7/2024Q4 2023-$0.53-$0.42+$0.11-$0.42-$0.22M11/8/2023Q3 2023-$0.57-$1.27 -$0.70-$1.27--$3.12M8/10/2023Q2 2023-$0.64-$0.68 -$0.04-$0.68-- Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023--$0.68 -$0.68-$0.68-$0.06M3/10/2023---$0.51 -$0.51-$0.03-- Lipocine Earnings - Frequently Asked Questions When is Lipocine's earnings date? Lipocine has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates. Learn more on LPCN's earnings history. How much revenue does Lipocine generate each year? Lipocine (NASDAQ:LPCN) has a recorded annual revenue of $7.92 million. How much profit does Lipocine generate each year? Lipocine (NASDAQ:LPCN) has a recorded net income of -$16.35 million. LPCN has generated -$0.76 earnings per share over the last four quarters. What is Lipocine's EPS forecast for next year? Lipocine's earnings are expected to decrease from ($0.78) per share to ($0.94) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Tonix Pharmaceuticals Earnings Date Lantern Pharma Earnings Date PDS Biotechnology Earnings Date BioAtla Earnings Date Anixa Biosciences Earnings Date Immunic Earnings Date Genelux Earnings Date X4 Pharmaceuticals Earnings Date Milestone Pharmaceuticals Earnings Date Relmada Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report A huge crack is forming in the US economy (Ad)Former Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”Learn how to protect yourself too, click here. This page (NASDAQ:LPCN) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredIs AI Hype Hiding the Big Picture?Jeff Bezos has loaded up on a tiny company being called "the Next Nvidia." If you've never heard of what I ...InvestorPlace | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your f...Priority Gold | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
